Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Dauricine may help treat certain brain cancers by reducing cancer cell growth and promoting cell death.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Targeting ornithine decarboxylase can help prevent skin cancer.

The drug combination was safe and showed promise in treating advanced tumors.

Blocking mTORC1 reduces skin tumor growth in mice.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Short-term treatment with ROCKi increases skin cell growth without changing stem cell features.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Suppressing ODC activity reduces tumor growth in hair follicles.

Janus Kinase Inhibitors are promising new treatments for various skin conditions due to their effectiveness and safety.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

c-Kit is important for heart regeneration and cancer development.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Mice with extra PKCδ resist chemical-induced skin cancer but not UV-induced.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

ATP-sensitive potassium channels are important for hair growth.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Antizyme slows skin tumor growth by reducing cell growth in mice.

PRIDE complex side effects from EGFR inhibitors can be managed without stopping treatment.

JAK inhibitors might help treat alopecia areata.